NBP
NovaBridge Biosciences
1.40$
-2.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | – | – | – | – | 100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | 0.1% | – | – | – | – | |
| 100.0% | – | -1,687.5% | 100.0% | – | – | – | – | 100.0% | – | – | – | – | |
| 2,271.4% | – | 3,429.8% | 152.8% | – | – | – | – | 1.3% | – | – | – | – | |
| 1,246.5% | – | 4,549.8% | 121.1% | – | – | – | – | 2.4% | – | – | – | – | |
| 3,517.8% | – | 7,979.7% | 273.9% | – | – | – | – | 3.8% | – | – | – | – | |
| -3,417.8% | – | -7,979.7% | -173.9% | – | – | – | – | -3.8% | – | – | – | – | |
| -3,931.8% | – | -6,162.2% | -81.5% | – | – | – | – | -2.9% | – | – | – | – | |
| – | – | – | 9.3% | – | – | – | – | -161.5% | – | – | – | – | |
| -3,931.8% | – | 1,835.2% | -46.1% | – | – | – | – | -2.9% | – | – | – | – | |
| 3,295.2% | – | -7,452.5% | -165.5% | – | – | – | – | -3.7% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.